Literature DB >> 15517477

Current concepts in functioning endocrine tumors of the pancreas.

Charles A G Proye1, Jonathan S Lokey.   

Abstract

Duodenal and pancreatic endocrine tumors are uncommon and their surgical treatment is often difficult. The management of these tumors has changed with recent advancements in tumor localization, intraoperative hormone measurements, standardized surgical techniques, and a better understanding of the genetic basis of multiple endocrine neoplasia syndrome. We present our experience with 191 endocrine tumors and elaborate the contemporary management of functioning duodenopancreatic endocrine tumors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15517477     DOI: 10.1007/s00268-004-7645-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  81 in total

1.  Preoperative localization of a neuroendocrine tumor of the pancreas with EUS-guided fine needle tattooing.

Authors:  Frank G Gress; Mohammed Barawi; Dong Kim; James H Grendell
Journal:  Gastrointest Endosc       Date:  2002-04       Impact factor: 9.427

2.  Unresponsiveness of insulinoma cells to secretin: significance of the secretin test in patients with insulinoma.

Authors:  M Imamura; Y Hattori; O Nishida; T Honda; Y Shimada; T Miyahara; T Wagata; N Baba; T Tobe
Journal:  Pancreas       Date:  1990-07       Impact factor: 3.327

Review 3.  Hepatic surgery for metastases from neuroendocrine tumors.

Authors:  Juan M Sarmiento; Florencia G Que
Journal:  Surg Oncol Clin N Am       Date:  2003-01       Impact factor: 3.495

4.  MEN1 gene mutations in 12 MEN1 families and their associated tumors.

Authors:  D Bartsch; I Kopp; A Bergenfelz; H Rieder; K Münch; K Jäger; Y Deiss; A Schudy; P Barth; R Arnold; M Rothmund; B Simon
Journal:  Eur J Endocrinol       Date:  1998-10       Impact factor: 6.664

5.  [Genetically-driven or supposed genetic-related insulinomas in adults: validation of the surgical strategy proposed by the A.F.C.E./G.E.N.E.M].

Authors:  C Proye; G Stalnikiewicz; J L Wemeau; N Porchet; M D'Herbomez; V Maunoury; C Bauters
Journal:  Ann Endocrinol (Paris)       Date:  2004-04       Impact factor: 2.478

6.  Possible primary lymph node gastrinoma: occurrence, natural history, and predictive factors: a prospective study.

Authors:  Jeffrey A Norton; H Richard Alexander; Douglas L Fraker; David J Venzon; Fathia Gibril; Robert T Jensen
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

7.  Pitfalls in the surgical treatment of insulinoma.

Authors:  Melanie L Richards; Paul G Gauger; Norman W Thompson; Robert G Kloos; Thomas J Giordano
Journal:  Surgery       Date:  2002-12       Impact factor: 3.982

8.  Impact of endoscopic ultrasound combined with fine-needle aspiration biopsy in the management of esophageal cancer.

Authors:  K J Chang; R M Soetikno; D Bastas; C Tu; P T Nguyen
Journal:  Endoscopy       Date:  2003-11       Impact factor: 10.093

Review 9.  Role of pancreatoduodenectomy in the management of primary duodenal wall gastrinomas in patients with Zollinger-Ellison syndrome.

Authors:  R Delcore; S R Friesen
Journal:  Surgery       Date:  1992-12       Impact factor: 3.982

10.  The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient.

Authors:  N W Thompson
Journal:  J Intern Med       Date:  1995-09       Impact factor: 8.989

View more
  12 in total

1.  Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1.

Authors:  Caroline L Lopez; Jens Waldmann; Volker Fendrich; Peter Langer; Peter H Kann; Detlef K Bartsch
Journal:  Langenbecks Arch Surg       Date:  2011-07-30       Impact factor: 3.445

Review 2.  Gastrointestinal manifestations of endocrine disease.

Authors:  Christina Maser; Arnbjorn Toset; Sanziana Roman
Journal:  World J Gastroenterol       Date:  2006-05-28       Impact factor: 5.742

3.  Accurate preoperative localization of insulinomas avoids the need for blind resection and reoperation: analysis of a single institution experience with 17 surgically treated tumors over 19 years.

Authors:  Brian K P Goh; London L P J Ooi; Peng-Chung Cheow; Yu-Meng Tan; Hock-Soo Ong; Yaw-Fui A Chung; Pierce K H Chow; Wai-Keong Wong; Khee-Chee Soo
Journal:  J Gastrointest Surg       Date:  2009-03-17       Impact factor: 3.452

Review 4.  Occult sporadic insulinoma: localization and surgical strategy.

Authors:  Bassam Abboud; Joe Boujaoude
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

Review 5.  Sporadic pancreatic polypeptide secreting tumors (PPomas) of the pancreas.

Authors:  Samuel C L Kuo; Sivakumar Gananadha; Christopher J Scarlett; Anthony Gill; Ross C Smith
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

6.  Management of insulinomas: analysis from a tertiary care referral center in India.

Authors:  Thomas V Paul; Jubbin J Jacob; Senthil K Vasan; Nihal Thomas; Simon Rajarathnam; Ben Selvan; M J Paul; Deepak Abraham; Aravindan Nair; M S Seshadri
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

7.  The expanding role of somatostatin analogs in the management of neuroendocrine tumors.

Authors:  Edward M Wolin
Journal:  Gastrointest Cancer Res       Date:  2012-09

Review 8.  Radiofrequency thermal ablation of metastatic neuroendocrine tumors in the liver.

Authors:  Peter J Mazzaglia; Eren Berber; Allan E Siperstein
Journal:  Curr Treat Options Oncol       Date:  2007-08

9.  Differentiation of insulin secretion patterns in insulinoma.

Authors:  Christiane Saddig; Peter E Goretzki; Achim A R Starke
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

10.  Cyto-reduction of neuroendocrine tumours using Sandostatin LAR in combination with Infergen: results of a case series.

Authors:  Hank S Wang; David S Oh; Gordon V Ohning; Joseph R Pisegna
Journal:  J Pharm Pharmacol       Date:  2006-12       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.